Skip to content
Screener

Medline, Inc. MDLN Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount at other companies

Baxter International logo
Baxter InternationalBAX
-$6.25M+51.0%
Henry Schein logo
Henry ScheinHSIC
$750K-50.0%
UFP Technologies logo
UFP TechnologiesUFPT
$0
CorMedix logo
CorMedixCRMD
-$15.18M-9,095%
MAG
MagneraMAGN
$7.75M+182%

Other financials

Income statement

See full
Revenue$7.7B+11.6%
Gross profit$2.2B+16.3%
Operating income$395.0M-38.5%
Net income$139.0M-57.8%
EPS (diluted)$0.07

Balance sheet

See full
Cash & equivalents$2.3B+299%
Total debt$12.6B
Total equity$11.6B
Total assets$39.4B

Cash flow

See full
Operating cash flow$715.0M+263%
CapEx$111.0M+0.9%
Free cash flow$604.0M+594%

Valuation

See full
Market cap$31B-0.3%
Enterprise value$41.29B
P/E34.9×
P/S1.1×

Profitability

See full
Gross margin27.5%+1.1pp
Operating margin8.7%+1.7pp
Net margin4.7%+1.8pp
FCF margin5.2%-0.6pp

Returns & leverage

See full
Return on equity7.8%
Debt / equity1.1×
Current ratio4.3×

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance.

The source filing: Medline, Inc.’s 10-K, filed February 25, 2026.

Filed
Feb 25, 2026, 4:51 PM EST
Fiscal year
FY2025
Accession
0002046386-26-000009
(in millions)Year ended / December 31, 2025Year ended / December 31, 2025Year ended / December 31, 2025
Statutory income tax rate differential (2)(19)(1.5)%
Effects of changes in tax laws or rates enacted in the current period20.1%
Effects of cross-border tax laws (3)20.2%
Changes in valuation allowance(1)(0.1)%
Nontaxable or non deductible items
Impact of non-taxable partnership earnings(160)(12.8)%
Other1
Income tax expense$$917.3%

Item 8 - Financial Statements and Supplementary Data

FAQ

What is Medline, Inc.'s effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount?
Medline, Inc. (MDLN) reported effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount of -$250K in Q4 2025.
What does effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount mean?
This metric reflects the dollar amount of changes in the valuation allowance for deferred tax assets, which represents management's assessment of the likelihood that these assets will be realized. A significant change can indicate shifts in the company's outlook on future profitability and the recoverability of tax benefits.

Ask your AI about Medline, Inc.'s effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude